Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 27th July 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Veterinary medicines containing diethanolamine suspended
The Veterinary Medicines Directorate (VMD) has suspended veterinary medicines containing diethanolamine.

VMD states excipient may pose a risk to humans

The Veterinary Medicines Directorate (VMD) has suspended veterinary medicines containing diethanolamine (DEA) over concerns the excipient may pose a risk to humans.

In a press release, the VMD said it had made the decision 'in light of scientific opinion of the Committee for Medicinal Products for Veterinary Use (CVMP)'. It states there may be a risk to humans from consuming food from animals treated with products containing DEA.

The affected products are as follows:

Product VM Number MAH
Allevinix 50 mg/ml Solution for Injection for Cattle, Pigs and Horses 15052/4144 Ceva Animal Health Ltd
Cronyxin Injection, 5% w/v Solution for Injection
 		 12597/4014 Cross Vetpharm Group Ltd
Dugnixon 50 mg/ml Solution for Injection for Cattle, Pigs and Horses 36167/4005 Global Vet Health S.L.
Finadyne 50 mg/ml Solution for Injection  01708/4582 Intervet UK Ltd
Flunixin 50 mg/ml Solution for Injection for Cattle, Horses and Pigs 02000/4170 Norbrook Laboratories Limited
Meflosyl 5% Solution for Injection 42058/4085 Zoetis UK Limited
Norixin 5% Solution for Injection 02000/4137 Norbrook Laboratories Limited
Pyroflam 50 mg/ml Solution for Injection for Cattle, Horses and Pigs 02000/4253
 		 Norbrook Laboratories Limited
Tribrissen 48% Suspension for Injection 01708/4593 Intervet UK Ltd

 

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.